Alkermes plc (NASDAQ:ALKS)’s traded shares stood at 1.01 million during the latest session, with the company’s beta value hitting 0.51. At the last check today, the stock’s price was $30.69, to imply an increase of 6.69% or $1.92 in intraday trading. The ALKS share’s 52-week high remains $36.45, putting it -18.77% down since that peak but still an impressive 25.38% since price per share fell to its 52-week low of $22.90. The company has a valuation of $5.06B, with an average of 1.87 million shares in intraday trading volume over the past 10 days and average of 1.87 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Alkermes plc (ALKS), translating to a mean rating of 1.93. Of 8 analyst(s) looking at the stock, 0 analyst(s) give ALKS a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.47.
Alkermes plc (NASDAQ:ALKS) trade information
After registering a 6.69% upside in the latest session, Alkermes plc (ALKS) has traded red over the past five days. The 5-day price performance for the stock is 10.93%, and -5.64% over 30 days. With these gigs, the year-to-date price performance is 6.73%. Short interest in Alkermes plc (NASDAQ:ALKS) saw shorts transact 12.35 million shares and set a 6.79 days time to cover.
The extremes give us $36 and $40 for target low and target high price respectively. As such, ALKS has been trading -30.34% off suggested target high and -17.3% from its likely low.
Alkermes plc (ALKS) estimates and forecasts
The rating firms project that company’s revenue will shrink -10.84% compared to the previous financial year.
Revenue forecast for the current quarter as set by 14 analysts is 346.57M. Meanwhile, for the current quarter, a total of 14 analyst(s) estimate revenue growth to 354.67M.Earnings reports from the last fiscal year show that sales brought in 399.13M and 378.14M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -13.17% before dropping -6.21% in the following quarter.
ALKS Dividends
Alkermes plc has its next earnings report out on 2025-Feb-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Alkermes plc (NASDAQ:ALKS)’s Major holders
Alkermes plc insiders hold 1.48% of total outstanding shares, with institutional holders owning 104.82% of the shares at 106.39% float percentage. In total, 104.82% institutions holds shares in the company, led by BLACKROCK INC.. As of 2024-06-30, the company held over 29.11 million shares (or 17.2929% of shares), all amounting to roughly $701.49 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 20.0 million shares, or about 11.882% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $482.0 million.
We also have iShares Trust-iShares Core S&P Small-Cap ETF and T. Rowe Price Mid-Cap Value Fund, Inc. as the top two Mutual Funds with the largest holdings of the Alkermes plc (ALKS) shares. Going by data provided on Mar 31, 2025 , iShares Trust-iShares Core S&P Small-Cap ETF holds roughly 10.06 shares. This is just over 6.10% of the total shares, with a market valuation of $307.25 million. Data from the same date shows that the other fund manager holds a little less at 5.2, or 3.15% of the shares, all valued at about 158.87 million.
